E-LIB Suche - Ergebnisse für: Warren, R B

1

MSR85 Psoriasis Symptoms and Impacts Measure: Identifying K..:

Warren, R.B. ; Augustin, M. ; Warham, R....
Value in Health. 26 (2023) 12 - p. S409 , 2023

Link: https://doi.org/10.1016/..

2

Drug survival and safety of biosimilars and originator adal..:

Phan, Duc Binh ; Jourdain, Hugo ; González-Quesada, Alicia...
BMJ Open. 13 (2023) 7 - p. e075197 , 2023

Link: https://doi.org/10.1136/..

3

CO10 A Matching-Adjusted Indirect Comparison of the Efficac..:

Mease, P.J. ; Warren, R.B. ; Nash, P....
Value in Health. 26 (2023) 12 - p. S16 , 2023

Link: https://doi.org/10.1016/..

4

PCR234 Impact of Draining Tunnels on Patient- and Physician..:

Kirby, J. ; Hamzavi, I. ; Villani, A.P....
Value in Health. 26 (2023) 6 - p. S356 , 2023

Link: https://doi.org/10.1016/..

5

MSR52 Defining Severity Category Thresholds to Guide Psoria..:

Augustin, M. ; Gottlieb, A.B. ; Warham, R....
Value in Health. 26 (2023) 12 - p. S402-S403 , 2023

Link: https://doi.org/10.1016/..

6

Tolérance à long terme du bimékizumab chez les patients att..:

Breban, M. ; Mease, P.J. ; Poddubnyy, D....
Revue du Rhumatisme. 90 (2023) - p. A188-A189 , 2023

Link: https://doi.org/10.1016/..

7

Long‐term, durable, absolute Psoriasis Area and Severity In..:

Gooderham, M. ; Pinter, A. ; Ferris, L.K....
Journal of the European Academy of Dermatology and Venereology. 36 (2022) 6 - p. 855-865 , 2022

Link: https://doi.org/10.1111/..

8

Le bimékizumab chez des patients atteints de rhumatisme pso..:

Gossec, L. ; Merola, J.F. ; McInnes, I.B....
Revue du Rhumatisme. 89 (2022) - p. A76-A77 , 2022

Link: https://doi.org/10.1016/..

9

Long‐term efficacy and safety of brodalumab in moderate‐to‐..:

Reich, K. ; Iversen, L. ; Puig, L....
Journal of the European Academy of Dermatology and Venereology. 36 (2022) 8 - p. 1275-1283 , 2022

Link: https://doi.org/10.1111/..

10

Secukinumab improves the quality‐of‐life of family members ..:

Finlay, A. Y. ; Barker, J. N. ; Burden, A. D....
JEADV Clinical Practice. 1 (2022) 3 - p. 207-218 , 2022

Link: https://doi.org/10.1002/..

11

Le bimékizumab chez des patients atteints de rhumatisme pso..:

Gossec, L. ; McInnes, I.B. ; Coates, L.C....
Revue du Rhumatisme. 89 (2022) - p. A74-A75 , 2022

Link: https://doi.org/10.1016/..

12

Three‐year efficacy and safety of certolizumab pegol for th..:

Warren, R. B. ; Lebwohl, M. ; Sofen, H....
Journal of the European Academy of Dermatology and Venereology. 35 (2021) 12 - p. 2398-2408 , 2021

Link: https://doi.org/10.1111/..

13

Describing the burden of the COVID‐19 pandemic in people wi..:

Mahil, S.K. ; Yates, M. ; Yiu, Z.Z.N....
Journal of the European Academy of Dermatology and Venereology. 35 (2021) 10 - p. , 2021

Link: https://doi.org/10.1111/..

14

Complete clearance and Psoriasis Area and Severity Index re..:

Reich, K. ; Hansen, J.B. ; Puig, L...
Journal of the European Academy of Dermatology and Venereology. 35 (2021) 10 - p. 2034-2044 , 2021

Link: https://doi.org/10.1111/..

15

Risk of COVID‐19 infection in adult patients with atopic ec..:

Yiu, Z.Z.N. ; Harding‐Oredugba, G. ; Griffiths, C.E.M....
British Journal of Dermatology. 185 (2021) 2 - p. 441-443 , 2021

Link: https://doi.org/10.1111/..